Business Description
Ananda Pharma PLC
ISIN : GB00BDQPXQ60
Share Class Description:
AQSE:ANA: Ordinary SharesCompare
Compare
Traded in other countries / regions
ANA.UK1FX.Germany IPO Date
2018-07-04Description
Ananda Pharma PLC is focused on the development of cannabinoid therapies for the treatment of a range of complex conditions. The company is developing NHS-approved and MHRA-licensed cannabinoid medicines for the treatment of drug-resistant epilepsies and specific inflammatory pain conditions (starting with CIPN & endometriosis) and HFpEF heart failure.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 65.61 | |||||
| 9-Day RSI | 64.05 | |||||
| 14-Day RSI | 63.08 | |||||
| 3-1 Month Momentum % | 15.58 | |||||
| 6-1 Month Momentum % | 18.67 | |||||
| 12-1 Month Momentum % | 28.99 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ananda Pharma PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | |||
| EPS (TTM) (£) | -0.002 | ||
| Beta | 1.59 | ||
| 3-Year Sharpe Ratio | 0.13 | ||
| 3-Year Sortino Ratio | 0.29 | ||
| Volatility % | 159.17 | ||
| 14-Day RSI | 63.08 | ||
| 14-Day ATR (£) | 0.000319 | ||
| 20-Day SMA (£) | 0.004923 | ||
| 12-1 Month Momentum % | 28.99 | ||
| 52-Week Range (£) | 0.002 - 0.0058 | ||
| Shares Outstanding (Mil) | 4,256.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ananda Pharma PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ananda Pharma PLC Stock Events
| Event | Date | Price (£) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ananda Pharma PLC Frequently Asked Questions
What is Ananda Pharma PLC(AQSE:ANA)'s stock price today?
The current price of AQSE:ANA is £0.01. The 52 week high of AQSE:ANA is £0.01 and 52 week low is £0.00.
When is next earnings date of Ananda Pharma PLC(AQSE:ANA)?
The next earnings date of Ananda Pharma PLC(AQSE:ANA) is .
Does Ananda Pharma PLC(AQSE:ANA) pay dividends? If so, how much?
Ananda Pharma PLC(AQSE:ANA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers